| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
|---|
|
| | | IP | CI | | CoAprovel 150/12.5 - T | 28 Tablet(s) | 10.19 | 27.45 | 10 % | | Coated tablets: 2 Active Agents | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | | G |  |
| | | IP | CI | | CoAprovel 150/12.5 - T | 98 Tablet(s) | 32.89 | 52.00 | 10 % | | Coated tablets: 2 Active Agents | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | | G | |
| | | IP | CI | | CoAprovel 300/12.5 - T | 28 Tablet(s) | 13.76 | 31.30 | 10 % | | Coated tablets: 2 Active Agents | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | | G | |
| | | IP | CI | | CoAprovel 300/12.5 - T | 98 Tablet(s) | 47.53 | 67.85 | 10 % | | Coated tablets: 2 Active Agents | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | | G | |
| | | IP | CI | | CoAprovel 300/25 - T | 28 Tablet(s) | 13.93 | 31.50 | 10 % | | Coated tablets: 2 Active Agents | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | | G | |
| | | IP | CI | | CoAprovel 300/25 - T | 98 Tablet(s) | 48.10 | 66.55 | 10 % | | Coated tablets: 2 Active Agents | Sanofi-Aventis
(Suisse) SA | B / SL / SO | FB | | G | |
| | | IP | CI | | Co-Irbesartan Sandoz
150/12,5 mg | 28 Tablet(s) | 9.29 | 26.50 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Irbesartan Sandoz
150/12,5 mg | 98 Tablet(s) | 29.98 | 49.00 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Irbesartan Sandoz
300/12,5 mg | 28 Tablet(s) | 12.55 | 30.05 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Irbesartan Sandoz
300/12,5 mg | 98 Tablet(s) | 43.33 | 63.55 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Irbesartan Sandoz
300/25 mg | 28 Tablet(s) | 12.70 | 30.25 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Irbesartan Sandoz
300/25 mg | 98 Tablet(s) | 43.84 | 64.10 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Irbesartan Spirig HC
150/12.5 mg | 28 Tablet(s) | 9.29 | 26.50 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Irbesartan Spirig HC
150/12.5 mg | 98 Tablet(s) | 29.98 | 49.00 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Irbesartan Spirig HC
300/12.5 mg | 28 Tablet(s) | 12.55 | 30.05 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Irbesartan Spirig HC
300/12.5 mg | 98 Tablet(s) | 43.33 | 63.55 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Irbesartan HCT Zentiva
150/12.5 mg | 28 Tablet(s) | 9.29 | 26.50 | 10 % | | Coated tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Irbesartan HCT Zentiva
150/12.5 mg | 98 Tablet(s) | 29.99 | 49.05 | 10 % | | Coated tablets: 2 Active Agents | Helvepharm AG | ● B / SL / SG | FB | | G | |
| | | IP | CI | | Irbesartan HCT Zentiva
300/12.5 mg | 28 Tablet(s) | 12.55 | 30.05 | 10 % | | Coated tablets: 2 Active Agents | Helvepharm AG | ● B / SL / SG | FB | | G | |
| | | IP | CI | | Irbesartan HCT Zentiva
300/12.5 mg | 98 Tablet(s) | 43.33 | 63.55 | 10 % | | Coated tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Irbesartan HCT Zentiva
300/25 mg | 28 Tablet(s) | 12.70 | 30.25 | 10 % | | Coated tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Irbesartan HCT Zentiva
300/25 mg | 98 Tablet(s) | 43.85 | 64.10 | 10 % | | Coated tablets: 2 Active Agents | Helvepharm AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Irbesartan-HCT-Mepha
150mg/12.5mg | 28 Tablet(s) | 9.25 | 26.50 | 10 % | | Coated tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Irbesartan-HCT-Mepha
150mg/12.5mg | 98 Tablet(s) | 29.84 | 48.90 | 10 % | | Coated tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Irbesartan-HCT-Mepha
300mg/12.5mg | 28 Tablet(s) | 12.49 | 30.00 | 10 % | | Coated tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Irbesartan-HCT-Mepha
300mg/12.5mg | 98 Tablet(s) | 43.11 | 63.30 | 10 % | | Coated tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Irbesartan-HCT-Mepha
300mg/25mg | 28 Tablet(s) | 12.64 | 30.15 | 10 % | | Coated tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Irbesartan-HCT-Mepha
300mg/25mg | 98 Tablet(s) | 43.63 | 63.90 | 10 % | | Coated tablets: 2 Active Agents | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Irbesartan Spirig HC
300/25 mg | 28 Tablet(s) | 12.70 | 30.25 | 10 % | | Filmtablette: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Irbesartan Spirig HC
300/25 mg | 98 Tablet(s) | 43.84 | 64.10 | 10 % | | Filmtablette: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
